Regulation And Legal
Cipla's InvaGen USFDA Inspection Gets VAI Classification
Cipla discloses USFDA classified its InvaGen subsidiary's Unit 3 facility inspection as Voluntary Action Indicated (VAI).
The inspection occurred from July 13-17, 2026, at the Central Islip, NY facili
